EasyDiagnosis

EasyDiagnosis, founded in 2008, is a specialized developer and manufacturer of in vitro diagnostic (IVD) products. Headquartered in the Hi-tech Development Zone of Wuhan, China, the company focuses on point-of-care testing (POCT) solutions. Their extensive product portfolio includes blood gas analysis, immunoassay systems, molecular diagnostics, and coagulation analysis tools. These sophisticated technologies are engineered to provide high-precision results for healthcare professionals operating in diverse clinical environments, ensuring that diagnostic accuracy is maintained across all levels of medical care.

The organization maintains a robust operational footprint, supporting over 7,000 medical facilities across more than 50 countries. With a dedicated workforce of 1,500 employees, the company emphasizes technical excellence and reliable diagnostic performance. Meet EasyDiagnosis's team to understand the leadership and technical expertise driving their global expansion and product innovation. Their commitment to quality ensures that medical testing remains accurate, efficient, and accessible for clinicians worldwide, fostering better patient outcomes through advanced biomedical engineering and rigorous manufacturing standards.

Operating within the Test & Measurement Equipment and Manufacturing sectors, EasyDiagnosis leverages advanced software and web-based decision support tools to enhance diagnostic workflows. The company’s annual revenue stands at $36.9M, reflecting its significant market presence and consistent growth since its inception. By integrating automated systems and interactive software, they continue to address the evolving needs of the global healthcare market. They maintain a strong competitive edge through continuous research and development, ensuring their diagnostic solutions remain at the forefront of the biomedical industry.